SenoRx wins patent infringement case

Dec 22 2009

Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the jury in the patent infringement lawsuit against SenoRx brought by Hologic, Cytyc Corp., and Hologic L.P., Inc. in the U.S. District Court for the Northern District of California has returned a verdict in favor of SenoRx.

The suit alleges SenoRx's Contura infringes claims 4 and 8 of U.S. Patents 6,413,204 and 6,482,142, respectively. The jury found that claim 4 was not infringed and found that both claims were not valid. SenoRx had previously admitted infringement of claim 8. "We are obviously disappointed in the jury's finding, however we believe the decision was based in part on an incorrect claim construction," said Mark Casey, Senior Vice President and General Counsel. "We plan to appeal the matter to the Court of Appeals for the Federal Circuit."

SOURCE Hologic, Inc.